| scholarly article | Q13442814 |
| P50 | author | El-Shaimaa A Arafa | Q57025588 |
| P2093 | author name string | Qun Zhao | |
| Altaf A Wani | |||
| Gulzar Wani | |||
| Mohamed A El-Mahdy | |||
| Qianzheng Zhu | |||
| Bassant M Barakat | |||
| P2860 | cites work | Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin | Q24313571 |
| Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes | Q24678624 | ||
| Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery | Q27860586 | ||
| NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase | Q28144326 | ||
| NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling | Q28144330 | ||
| Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease | Q28207980 | ||
| Inhibitory effects of the tyrosine kinase inhibitor genistein on mammalian DNA topoisomerase II | Q28253570 | ||
| Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt | Q28255373 | ||
| Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro | Q28266942 | ||
| Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization | Q28290083 | ||
| Oncogenes and signal transduction | Q29547804 | ||
| New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway | Q29616144 | ||
| Cytotoxic mechanism of flavonoid from Temu Kunci (Kaempferia pandurata) in cell culture of human mammary carcinoma. | Q30665653 | ||
| Flavonoids inhibit cell growth and induce apoptosis in B16 melanoma 4A5 cells | Q31512518 | ||
| Topoisomerase I poisons and suppressors as anticancer drugs | Q33179504 | ||
| Dietary flavone is a potent apoptosis inducer in human colon carcinoma cells | Q33180798 | ||
| Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. | Q33960065 | ||
| IKK/NF-kappaB signaling: balancing life and death--a new approach to cancer therapy | Q34048503 | ||
| Flavonoids: a review of probable mechanisms of action and potential applications | Q34376410 | ||
| Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells | Q34439326 | ||
| PI3K/Akt and apoptosis: size matters | Q35603373 | ||
| The epigenetics of ovarian cancer drug resistance and resensitization | Q35952377 | ||
| Mechanisms of platinum drug resistance | Q36062568 | ||
| Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? | Q36068139 | ||
| The anti-death machinery in IKK/NF-kappaB signaling | Q36354713 | ||
| Using chemopreventive agents to enhance the efficacy of cancer therapy | Q36439479 | ||
| Proteins associated with Cisplatin resistance in ovarian cancer cells identified by quantitative proteomic technology and integrated with mRNA expression levels | Q39737951 | ||
| Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells | Q40188424 | ||
| Tangeretin suppresses IL-1beta-induced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells | Q40215205 | ||
| Cisplatin-induced apoptosis in human promyelocytic leukemia cells. | Q40251885 | ||
| Quercetin-induced apoptosis in the monoblastoid cell line U937 in vitro and the regulation of heat shock proteins expression | Q40825003 | ||
| Signal pathways involved in apigenin inhibition of growth and induction of apoptosis of human anaplastic thyroid cancer cells (ARO). | Q40907122 | ||
| Cisplatin- and paclitaxel-induced apoptosis of ovarian carcinoma cells and the relationship between bax and bak up-regulation and the functional status of p53. | Q41032773 | ||
| The novel cyclin-dependent kinase inhibitor flavopiridol downregulates Bcl-2 and induces growth arrest and apoptosis in chronic B-cell leukemia lines. | Q41075336 | ||
| Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin-dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells | Q44177064 | ||
| Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization | Q45182288 | ||
| A safety study of oral tangeretin and xanthohumol administration to laboratory mice | Q46408877 | ||
| Thymoquinone induces apoptosis through activation of caspase-8 and mitochondrial events in p53-null myeloblastic leukemia HL-60 cells | Q46500593 | ||
| Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway | Q47762057 | ||
| Cisplatin, camptothecin, and taxol sensitivities of cells with p53-associated multidrug resistance | Q58282980 | ||
| A Bad kinase makes good | Q59099312 | ||
| Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues | Q68922078 | ||
| Apoptosis meets signal transduction: elimination of a BAD influence | Q71802220 | ||
| Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells | Q95810045 | ||
| P433 | issue | 23 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | ovarian cancer | Q172341 |
| P304 | page(s) | 8910-8917 | |
| P577 | publication date | 2009-11-10 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway | |
| P478 | volume | 69 |
| Q30355266 | A randomized trial of diet and physical activity in women treated for stage II-IV ovarian cancer: Rationale and design of the Lifestyle Intervention for Ovarian Cancer Enhanced Survival (LIVES): An NRG Oncology/Gynecologic Oncology Group (GOG-225) S |
| Q36129967 | A unique histone deacetylase inhibitor alters microRNA expression and signal transduction in chemoresistant ovarian cancer cells |
| Q34340354 | Agonist activation of estrogen receptor beta (ERβ) sensitizes malignant pleural mesothelioma cells to cisplatin cytotoxicity. |
| Q37145579 | Anti-Inflammatory Effect of Quercetagetin, an Active Component of Immature Citrus unshiu, in HaCaT Human Keratinocytes |
| Q38698041 | Antioxidant Capacity, Anticancer Ability and Flavonoids Composition of 35 Citrus (Citrus reticulata Blanco) Varieties. |
| Q38933444 | Brown algae phlorotannins enhance the tumoricidal effect of cisplatin and ameliorate cisplatin nephrotoxicity |
| Q28066511 | Chemopreventive Agents and Inhibitors of Cancer Hallmarks: May Citrus Offer New Perspectives? |
| Q42202353 | Combination of bladder cancer-specific oncolytic adenovirus gene therapy with cisplatin on bladder cancer in vitro |
| Q39468735 | Costunolide induces apoptosis in platinum-resistant human ovarian cancer cells by generating reactive oxygen species |
| Q38791391 | Curcumin induced apoptosis via PI3K/Akt-signalling pathways in SKOV3 cells |
| Q49289835 | Dietary flavonoid tangeretin induces reprogramming of epithelial to mesenchymal transition in prostate cancer cells by targeting the PI3K/Akt/mTOR signaling pathway |
| Q53119009 | Enhanced Anti-Inflammatory Activities by the Combination of Luteolin and Tangeretin. |
| Q44295635 | Enhancing conventional chemotherapy drug cisplatin-induced anti-tumor effects on human gastric cancer cells both in vitro and in vivo by Thymoquinone targeting PTEN gene |
| Q33782251 | Flavonoids: an overview |
| Q31057778 | GRP78 knockdown enhances apoptosis via the down-regulation of oxidative stress and Akt pathway after epirubicin treatment in colon cancer DLD-1 cells |
| Q46560077 | Gene expression analysis identifies two groups of ovarian high-grade serous carcinomas with different prognosis |
| Q21199589 | Identifying microRNA/mRNA dysregulations in ovarian cancer |
| Q39663853 | Inhibition of phosphatidylinositol 3-kinase promotes tumor cell resistance to chemotherapeutic agents via a mechanism involving delay in cell cycle progression |
| Q49389276 | Kaempferol mitigates Endoplasmic Reticulum Stress Induced Cell Death by targeting caspase 3/7. |
| Q36682159 | Medroxyprogestogen enhances apoptosis of SKOV-3 cells via inhibition of the PI3K/Akt signaling pathway |
| Q38587869 | Mitochondrial dynamics regulating chemoresistance in gynecological cancers |
| Q35064507 | Molecular mechanism of apoptosis induction in skin cancer cells by the centipedegrass extract |
| Q36357895 | Nanog signaling in cancer promotes stem-like phenotype and immune evasion |
| Q34361586 | Perifosine induces cell cycle arrest and apoptosis in human hepatocellular carcinoma cell lines by blockade of Akt phosphorylation |
| Q39460592 | Phosphatidylinositol 3-kinase-C2β inhibits cisplatin-mediated apoptosis via the Akt pathway in oesophageal squamous cell carcinoma |
| Q33908881 | Phytochemicals: a multitargeted approach to gynecologic cancer therapy. |
| Q45719581 | Pro-apoptotic effects of the novel tangeretin derivate 5-acetyl-6,7,8,4'-tetramethylnortangeretin on MCF-7 breast cancer cells. |
| Q64101413 | Proteomics Analysis of Tangeretin-Induced Apoptosis through Mitochondrial Dysfunction in Bladder Cancer Cells |
| Q36413165 | RY-2f, an isoflavone analog, overcomes cisplatin resistance to inhibit ovarian tumorigenesis via targeting the PI3K/AKT/mTOR signaling pathway |
| Q33582882 | SERPINA3 promotes endometrial cancer cells growth by regulating G2/M cell cycle checkpoint and apoptosis |
| Q43645519 | Sensitisation of ovarian cancer cells to cisplatin by flavonoids from Scutellaria barbata |
| Q34227763 | Sensitization of ovarian cancer cells to cisplatin by gold nanoparticles |
| Q34663180 | Simultaneous quantification of paeoniflorin, nobiletin, tangeretin, liquiritigenin, isoliquiritigenin, liquiritin and formononetin from Si-Ni-San extract in rat plasma and tissues by liquid chromatography-tandem mass spectrometry |
| Q39472173 | Some natural flavonoids are competitive inhibitors of Caspase-1, -3 and -7 despite their cellular toxicity |
| Q35975350 | Tangeretin Alleviates Cisplatin-Induced Acute Hepatic Injury in Rats: Targeting MAPKs and Apoptosis. |
| Q34837773 | Tangeretin and its metabolite 4'-hydroxytetramethoxyflavone attenuate EGF-stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6K |
| Q38500801 | Targeting TRAIL in the treatment of cancer: new developments. |
| Q39268041 | Tectorigenin sensitizes paclitaxel-resistant human ovarian cancer cells through downregulation of the Akt and NFκB pathway |
| Q37488549 | The diarylheptanoid hirsutenone sensitizes chemoresistant ovarian cancer cells to cisplatin via modulation of apoptosis-inducing factor and X-linked inhibitor of apoptosis. |
| Q35636447 | The flavonoid nobiletin inhibits tumor growth and angiogenesis of ovarian cancers via the Akt pathway |
| Q33697116 | The multiple facets of drug resistance: one history, different approaches |
| Q64902978 | Three Polymethoxyflavones Purified from Ougan (Citrus reticulata Cv. Suavissima) Inhibited LPS-Induced NO Elevation in the Neuroglia BV-2 Cell Line via the JAK2/STAT3 Pathway. |
| Q28536969 | Thymoquinone inhibits autophagy and induces cathepsin-mediated, caspase-independent cell death in glioblastoma cells |
| Q34566017 | Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells |
| Q37652592 | Twist2 contributes to cisplatin-resistance of ovarian cancer through the AKT/GSK-3β signaling pathway |
Search more.